They found that MiRNA-34a was a more accurate marker for the diagnosis of NASH compared to CK-18, FIB-4 (Fibrosis index based on 4 factors), and APRI, with AUROC of 0.811 (95% CI: 0.670–0.953). Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.